Regulatory uncertainties abound with presidential two-for-one order

The Trump administration seems to be serious about reducing the cost and burden of regulations. The question observers are asking is how those efforts will eventually shake out. One the administration’s latest initiatives is an executive order signed by the President that would require federal agencies, such as the FDA, to eliminate two regulations for every new one it wants to issue. The order also mandates that the cost of a new regulation should be offset “to the extent permitted by law.”

Industry makes a move on RTSM mobile apps

Parexel has launched a mobile app to extend its ClinPhone randomization and trial supply management (RTSM) service. The app employs barcode scanning technology that enables investigative site staff to track study medications and manage supply-related tasks throughout clinical trials.

To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information.